Excelsior Biopharma (6496)

Currency in TWD
24.65
0.00(0.00%)
Closed·
6496 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
24.1524.65
52 wk Range
22.5030.55
Key Statistics
Bid/Ask
28.85 / 29.10
Prev. Close
29
Open
24.4
Day's Range
24.15-24.65
52 wk Range
22.5-30.55
Volume
8.46K
Average Volume (3m)
9.37K
1-Year Change
-16.2988%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6496 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
Aug 07, 2026
EPS / Forecast
-1.24 / --
Revenue / Forecast
232.49M / --
EPS Revisions
Last 90 days

6496 Income Statement

Compare 6496 to Peers and Sector

Metrics to compare
6496
Peers
Sector
Relationship
P/E Ratio
−5.6x40.7x−0.4x
PEG Ratio
0.100.010.00
Price/Book
1.7x2.7x2.6x
Price / LTM Sales
1.2x0.7x3.0x
Upside (Analyst Target)
-−6.8%54.3%
Fair Value Upside
Unlock5.2%7.2%Unlock

Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally. It offers general pharmaceuticals; orphan drugs; antidotes; rapid test kits and reagent; consumer products under the Repavar, Om3gafort, Oral7, and Excelsior Probiotics brand names; and over the counter drugs under the Norit, Puresenna, and Tazac brand names. The company also provides specialty medicine and public health products. In addition, it is involved in importing and exporting of active pharmaceutical ingredients, food, and cosmeceuticals; development of cosmetics; research, importing and exporting of technologies; and pharmaceutical technologies transfer. The company was formerly known as Excelsior Enterprise Co., Ltd. and changed its name to Excelsior Biopharma Inc. in June 2003. Excelsior Biopharma Inc. was founded in 1986 and is headquartered in Taipei, Taiwan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
15.47M33.21%381.30M
Public Companies & Retail Investors
31.11M66.79%766.85M
Total
46.58M100.00%1.15B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Yishihua Investment Co., Ltd.21.82%10,163,443250,529
Tuode Investment Co., Ltd.6.56%3,055,00075,306

FAQ

What Is the Excelsior Biopharma (6496) Stock Price Today?

The Excelsior Biopharma stock price today is 24.65 TWD.

What Stock Exchange Does Excelsior Biopharma Trade On?

Excelsior Biopharma is listed and trades on the Taipei Exchange.

What Is the Stock Symbol for Excelsior Biopharma?

The stock symbol for Excelsior Biopharma is "6496."

What Is the Excelsior Biopharma Market Cap?

As of today, Excelsior Biopharma market cap is 1.15B TWD.

What Is Excelsior Biopharma's Earnings Per Share (TTM)?

The Excelsior Biopharma EPS (TTM) is -4.46.

From a Technical Analysis Perspective, Is 6496 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Excelsior Biopharma Stock Split?

Excelsior Biopharma has split 0 times.

What is the current trading status of Excelsior Biopharma (6496)?

As of Sep 21, 2026, Excelsior Biopharma (6496) is trading at a price of 24.65 TWD, with a previous close of 29.00 TWD. The stock has fluctuated within a day range of 24.15 TWD to 24.65 TWD, while its 52-week range spans from 22.50 TWD to 30.55 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.